Resultados da busca - Mansouri, Sheila
- Mostrando 1 - 20 resultados de 43
- Ir para a próxima página
-
1
Neddylation in glioblastomas por Mansouri, Sheila, Zadeh, Gelareh
Publicado em 2015Texto -
2
-
3
-
4
Changes in the Nasopharyngeal Carcinoma Nuclear Proteome Induced by the EBNA1 Protein of Epstein-Barr Virus Reveal Potential Roles for EBNA1 in Metastasis and Oxidative Stress Resp... por Cao, Jennifer Yinuo, Mansouri, Sheila, Frappier, Lori
Publicado em 2012Texto -
5
-
6
-
7
The Evolving Role of Radiosurgery in the Management of Radiation-Induced Meningiomas: A Review of Current Advances and Future Directions por Mansouri, Alireza, Badhiwala, Jetan, Mansouri, Sheila, Zadeh, Gelareh
Publicado em 2014Texto -
8
-
9
-
10
-
11
GENE-26. MOLECULAR CHARACTERIZATION OF BENIGN AND MALIGNANT PERIPHERAL NERVE SHEATH TUMORS THAT OCCUR IN SPORADIC AND SYNDROMIC SETTINGS por Suppiah, Suganth, Karimi, Shirin, Mansouri, Sheila, Mamatjan, Yasin, Liu, Jeff, Aldape, Kenneth, Zadeh, Gelareh
Publicado em 2018Texto -
12
-
13
TMIC-16. THE IMMUNO-PROTECTIVE FUNCTION OF GLIOMA-ASSOCIATED BONE MARROW DERIVED CELLS DEPENDS ON THE STAGE OF TUMOR GROWTH AND IS INFLUENCED BY TREATMENT WITH MINOCYCLINE por Mansouri, Sheila, Burrell, Kelly, Yasin, Mamatjan, Agnihotri, Sameer, Nejad, Romina, Zhao, Tansy, Aldape, Kenneth, Zadeh, Gelareh
Publicado em 2017Texto -
14
MNGI-12. EXPRESSION OF PROGRAMMED CELL DEATH LIGAND-1 (PD-L1) IN MENINGIOMA: CLINICAL UTILITY FOR PREDICTION OF TUMOR RECURRENCE AND ASSOCIATION WITH HYPOXIC RESPONSE AND NFKB2 ACT... por Karimi, Shirin, Suppiah, Suganth, Mansouri, Sheila, Nassiri, Farshad, Mamatjan, Yasin, Liu, Jeff, Aldape, Kenneth, Zadeh, Gelareh
Publicado em 2018Texto -
15
Molecular and Clinical Insights into the Invasive Capacity of Glioblastoma Cells por Velásquez, Carlos, Mansouri, Sheila, Mora, Carla, Nassiri, Farshad, Suppiah, Suganth, Martino, Juan, Zadeh, Gelareh, Fernández-Luna, José L.
Publicado em 2019Texto -
16
Programmed death ligand-1 (PD-L1) expression in meningioma; prognostic significance and its association with hypoxia and NFKB2 expression por Karimi, Shirin, Mansouri, Sheila, Mamatjan, Yasin, Liu, Jeff, Nassiri, Farshad, Suppiah, Suganth, Singh, Olivia, Aldape, Kenneth, Zadeh, Gelareh
Publicado em 2020Texto -
17
Clinical significance of checkpoint regulator “Programmed death ligand-1 (PD-L1)” expression in meningioma: review of the current status por Karimi, Shirin, Mansouri, Sheila, Nassiri, Farshad, Bunda, Severa, Singh, Olivia, Brastianos, Priscilla K., Dunn, Ian F., Zadeh, Gelareh
Publicado em 2021Texto -
18
Liquid Biomarkers for Improved Diagnosis and Classification of CNS Tumors por Bunda, Severa, Zuccato, Jeffrey A., Voisin, Mathew R., Wang, Justin Z., Nassiri, Farshad, Patil, Vikas, Mansouri, Sheila, Zadeh, Gelareh
Publicado em 2021Texto -
19
PATH-21. CLINICAL UTILITY OF DNA METHYLATION PROFILING FOR DIAGNOSIS OF CHALLENGING CENTRAL NERVOUS SYSTEM TUMORS: THE TORONTO EXPERIENCE por Karimi, Shirin, Zuccato, Jeffrey, Mamatjan, Yasin, Mansouri, Sheila, Suppiah, Suganth, Nassiri, Farshad, Diamandis, Phedias, Munoz, David, Aldape, Kenneth, Zadeh, Gelareh
Publicado em 2019Texto -
20
GENE-08. SCHWANNOMATOSIS SCHWANNOMAS HARBOR DISTINCT DNA METHYLATION PROFILES por Mansouri, Sheila, Paganini, Irene, Karimi, Shirin, Suppiah, Suganth, Mamatjan, Yasin, Singh, Olivia, Stemmer-Rachamimov, Anat, Papi, Laura, Aldape, Kenneth, Zadeh, Gelareh
Publicado em 2018Texto